Acadia Pharmaceuticals | Capitalisation Boursière



Market Capitalization Changement Date
Acadia Pharmaceuticals USD 3.61B 840M 2025-06
ALKERMES USD 4.72B 725M 2025-06
Alnylam Pharmaceuticals USD 42.52B 7.39B 2025-06
Biogen USD 18.41B 1.62B 2025-06
BioMarin Pharmaceutical USD 10.54B 3.01B 2025-06
Bristol-Myers Squibb USD 94.2B 29.9B 2025-06
Corcept Therapeutics USD 7.78B 4.27B 2025-06
Cytokinetics USD 3.95B 846M 2025-06
Eli Lilly USD 738.79B 2.87B 2025-06
Incyte USD 13.18B 1.46B 2025-06
J&J USD 366.71B 32.94B 2025-06
Moderna USD 10.67B 290M 2025-06
Neurocrine Biosciences USD 12.44B 1.5B 2025-06
Pfizer USD 137.53B 6.19B 2025-06
Prothena USD 441M 114M 2025-09
PTC Therapeutics USD 3.87B 148M 2025-06
Sarepta Therapeutics USD 1.68B 4.51B 2025-06
Ultragenyx Pharmaceutical USD 3.44B 38M 2025-06
Vertex Pharmaceuticals USD 114.33B 10.31B 2025-06


Acadia Pharmaceuticals Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.